MedTrace Logo

S.A.F.E.BT System Extracorporeal Treatment With DIAPACT CRRT

NCT01312675 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-10-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if Selective Adsorption System for Removal of Bacterial Toxins (S.A.F.E.BT) therapy is effective in the treatment of severe sepsis.

Conditions

  • Severe Sepsis

Interventions

DEVICE

S.A.F.E.BT

Five (5) S.A.F.E.BT treatments within a 7 day treatment period.

Sponsors & Collaborators

  • B. Braun Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Wilkins, MBChB FRCA · BBraun Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2015-03-31
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01312675 on ClinicalTrials.gov